Result of the TELEDIAB-1 study, in which the digital therapeutic Diabeo® has shown improvement in HbA1c by 0.9% vs controls in patients with chronic, poorly controlled type 1 diabetes. Diabeo® provided two main functions: automated advice on the insulin doses required; and remote monitoring by teleconsultati
